LAWSUITS NEWS & LEGAL INFORMATION
Vytorin Linked to Increased Risk for Cancer
Results from a new study of Vytorin, the SEAS study, just released, show a 50 percent increased incidence of cancer among people who were taking the cholesterol-lowering drug, compared to those on placebo. Additionally, the drug failed to show any slowing of aeortic stenosis, the primary of study endpoint. Investigators are forwarding their findings to the FDA and other regulatory agencies in countries where the drug is approved.
JUL-21-08: Ezetimibe/Simvastatin (Vytorin) Misses Major Cardiovascular Endpoints in SEAS Trial [MEDPAGE TODAY: VYTORIN ]
Last updated on
JUL-21-08: Ezetimibe/Simvastatin (Vytorin) Misses Major Cardiovascular Endpoints in SEAS Trial [MEDPAGE TODAY: VYTORIN ]
Legal Help
If you or a loved one has suffered ill health effects, injury or damages as a result of using this drug, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.Last updated on
LEGAL ARTICLES AND INTERVIEWS
Zetia and Vytorin Continue to be Controversial
Attorney Ben Stewart: Vytorin “Controversial”
August 28, 2017
Washington, DC: There is little doubt that the cholesterol-fighting drug Zetia (ezetimibe) has travelled a rocky road since it was first approved by the US Food and Drug Administration (FDA) in 2002. And while several years have passed since the controversial delay in releasing study results into potential Zetia side effects, issues involving Zetia and its cousin Vytorin (Zetia in combination with a statin) continue to lazily percolate like water at a gentle boil. READ MORE
Attorney Ben Stewart: Vytorin “Controversial”
March 7, 2013
With a study about Vytorin expected in the next month or two, patients deciding whether or not to use the medication must rely on previous studies regarding Vytorin side effects. Those studies suggest that Vytorin can cause serious adverse reactions, according to Ben Stewart, attorney at Stewart Law, PLLC. Although there are no personal injury lawsuits currently working their way through the courts, that could change, depending on what the anticipated study shows. READ MORE
READ MORE Drugs/Medical Settlements and Legal News